GNUS
Genius Brands International Inc
-61.31%
$6.54 - $2.53
Feb 8th 2023 - Mar 22nd 2023
Jan, 20, 2023
$HTGM primed for $10+: STRONG BUY signal 700K flo... See more
Jan, 5, 2023
$GNUS our operating costs are nothing compared to ... See more
Divihomes is Now Live
A new search platform that matches you with the best home improvement service providers in your area.
Instant Search & Match with Top Contractors
Instant Communication with Local Contractors
Millions of Unbiased User Reviews
100% Free Quotes from Top-Notch Contractors
TGTX
TG Therapeutics Inc
-19.05%
$18.43 - $14.92
Feb 7th 2023 - Mar 21st 2023
Feb, 4, 2023
It’s not just the efficacy and safety of the produ... See more
Dec, 30, 2022
The analyst comments "TGTX stock is up >15... See more
Mar, 22, 2023
$COST almost!
Mar, 22, 2023
$COST this dude 🤡🤣🤣🤣
Mar, 22, 2023
$COST The bullish trend in the options market suggests a positive outlook for the stock We are seeing the $450 CALL having heavy activity which expire in 38 days.
Mar, 21, 2023
$COST 💵long 💅
Mar, 20, 2023
$COST 🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣
Mar, 20, 2023
$COST nice wedge here 🫡🔒 all I gottta say 🤫
Mar, 18, 2023
$COST Love Costco as much as anyone
Mar, 17, 2023
$COST 2hr looking bullish, she wanna touch the 200 day which is 296, juicy
Mar, 16, 2023
$COST The chart points towards an optimistic outlook for the stock.
Mar, 15, 2023
$COST Always a buy in the 470s, congratulations to those who got it this a.m.
Jan, 20, 2023
$HTGM primed for $10+: STRONG BUY signal 700K float 500%+ Cost to Borrow $3M MC w/ $14M in cash Recent analyst targets of $15.00+ Excellent technical setup Also watching: $WISA $SLRX $GNUS
Jan, 5, 2023
$GNUS our operating costs are nothing compared to the potential of what this could do I think something just sunk in big time holy smokes
Dec, 30, 2022
Increase revenues offset operation costs and in turn cash free flow = profit
Feb, 4, 2023
It’s not just the efficacy and safety of the product, it is the less cost for hospital/infusion, due to one hour infusion and the huge difference in price.
Dec, 30, 2022
The analyst comments "TGTX stock is up >15% (versus +4% for XBI) driven by: 1) positive comments on pricing: we think list price is rational with some discount vs. Ocrevus to lower cost burden and get broad access,
Dec, 30, 2022
Each treatment cost under $10k per treatment.
Dec, 30, 2022
Each treatment cost under $10k per treatment.
Dec, 29, 2022
The analyst comments "TGTX stock is up >15% (versus +4% for XBI) driven by: 1) positive comments on pricing: we think list price is rational with some discount vs. Ocrevus to lower cost burden and get broad access,